Because robust human safety data are limited, it is difficult to give a definitive side-effect profile with meaningful incidence rates
The other thing worth setting expectations on: outcomes vary
Technical Characteristics Compound name: GHK-Cu Full designation: Glycyl-L-Histidyl-L-Lysine Copper Type: Synthetic copper-complex peptide Form: Lyophilized powder Purity: 98% Regulatory status: Research Use Only (RUO) Classification: Not intended for clinical, therapeutic, or cosmetic use All batches are analyzed to ensure identity, purity, and consistency, meeting the requirements for scientific research applications
The mismatch isn't fatal to results, but it's suboptimal
Glucuronidation Increases BUT Is Insufficient While glucuronidation (the other safe pathway) does increase during pregnancy: This increase in glucuronidation CANNOT compensate for the simultaneous: 33% decrease in sulfation (another safe pathway) 80% increase in oxidation to toxic NAPQI **The Result:** When both safe pathways become saturated or overwhelmed, significantly more acetaminophen is forced through the toxic CYP2E1 pathway, creating 43% more NAPQIat precisely the time when glutathione reserves are most depleted
Professional, clean and top notch providers
